BYAH

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-41.38	Insider Own	63.62%	Shs Outstand	0.68M	Perf Week	-16.30%
Market Cap	4.37M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.25M	Perf Month	-69.20%
Enterprise Value	0.76M	PEG	-	EPS next Q	-	Inst Own	1.99%	Short Float	11.42%	Perf Quarter	-87.05%
Income	-24.36M	P/S	1.73	EPS this Y	-	Inst Trans	-	Short Ratio	0.11	Perf Half Y	-93.09%
Sales	2.52M	P/B	0.26	EPS next Y	-	ROA	-539.29%	Short Interest	0.03M	Perf YTD	-80.63%
Book/sh	5.90	P/C	1.15	EPS next 5Y	-	ROE	-885.84%	52W High	2074.50 -99.93%	Perf Year	-99.55%
Cash/sh	1.34	P/FCF	-	EPS past 3/5Y	- -	ROIC	-598.53%	52W Low	1.50 3.01%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.57% -	Gross Margin	90.64%	Volatility	8.81% 19.49%	Perf 5Y	-
Dividend TTM	-	EV/Sales	0.30	EPS Y/Y TTM	-1528.22%	Oper. Margin	-956.45%	ATR (14)	0.53	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.88	Sales Y/Y TTM	6.00%	Profit Margin	-965.00%	RSI (14)	23.86	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	2.92	EPS Q/Q	-985.57%	SMA20	-39.49%	Beta	-3.66	Target Price	-
Payout	-	Debt/Eq	0.05	Sales Q/Q	-15.91%	SMA50	-71.75%	Rel Volume	0.13	Prev Close	1.58
Employees	41	LT Debt/Eq	0.02	Earnings	-	SMA200	-99.23%	Avg Volume	270.03K	Price	1.54
IPO	Dec 27, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	33,758	Change	-2.53%

Jan-28-26 04:10PM	Park Ha Biological Technology Co., Ltd. Announces Closing of a US$2.45 Million Public Offering (GlobeNewswire) +12.61% -23.60%
Jan-27-26 08:30AM	Park Ha Biological Technology Co., Ltd. Announces Pricing of US$2.45 Million Best-Efforts Follow-on Public Offering (GlobeNewswire) -24.08%
Oct-24-25 09:26AM	Park Ha Biological Technology Co., Ltd. Announces Nasdaq Ticker Symbol Change to BYAH (GlobeNewswire) +5.39%
Aug-18-25 12:00AM	I almost fell off my chair: Investors lose billions on meme stocks as pump and dump scams multiply (Financial Times)
Apr-30-25 06:21AM	Why Park Ha Biological Technology Co., Ltd. (PHH) is Surging in 2025 (Insider Monkey)
05:03AM	Loading…
Mar-31-25 05:03AM	Park Ha Biological Technology: Growth Potential And Profitability Concerns (Seeking Alpha)
Mar-25-25 09:24AM	Why Park Ha Biological Technology Co Ltd (PHH) Is Surging In 2025? (InsiderMonkey) -11.83%
Mar-09-25 06:02PM	Why Park Ha Biological Technology Co., Ltd. (PHH) Soared Last Week (Insider Monkey)
Jan-06-25 08:00AM	D. Boral Capital Served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering (GlobeNewswire) +7.05%
Dec-30-24 05:30PM	Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering (GlobeNewswire) +19.16% +29.69%
Dec-26-24 09:46PM	Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering (GlobeNewswire)

Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. It operates through the Product Sales and Franchise Fees segments. The company was founded by Xiao Qiu Zhang on October 11, 2022 and is headquartered in Wuxi, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Park Ha Biological Technology Co Ltd

Upgrade your FINVIZ experience